Organon & Co.
DE ˙ XTRA
11,54 € ↑0,06 (0,52%)
2026-06-03
AKTIENPREIS
SecurityDE:7XP / Organon & Co.
InstitutionCoreCap Advisors, LLC
Latest Disclosed Ownership223 shares
Latest Disclosed Value $ 1,336
CoreCap Advisors, LLC reports 4.69% increase in ownership of 7XP / Organon & Co.

On April 7, 2026 - CoreCap Advisors, LLC filed a 13F-HR form disclosing ownership of 223 shares of Organon & Co. (DE:7XP) valued at $1,153 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 13, 2026 disclosing 213 shares of Organon & Co.. This represents a change in shares of 4.69% during the quarter. The current value of the position is $2,572 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-07 2026-03-31 13F ORGANON & CO Stock 68622V106 223 10 4.69 1 0.00 0.0000
2026-01-13 2025-12-31 13F ORGANON & CO Stock 68622V106 213 -148 -41.00 2 -66.67 0.0001
2025-10-22 2025-09-30 13F ORGANON & CO Stock 68622V106 361 -7 -1.90 4 0.00 0.0001
2025-08-14 2025-06-30 13F ORGANON & CO Stock 68622V106 368 134 57.26 4 0.00 0.0001
2025-05-09 2025-03-31 13F ORGANON COMMON STOCK 68622V106 234 -17 -6.77 3 0.00 0.0002
2025-02-14 2024-12-31 13F ORGANON COMMON STOCK 68622V106 251 105 71.92 4 50.00 0.0002
2024-11-08 2024-09-30 13F ORGANON COMMON STOCK 68622V106 146 -43 -22.75 3 -33.33 0.0001
2024-08-08 2024-06-30 13F ORGANON COMMON STOCK 68622V106 189 -81 -30.00 4 -40.00 0.0004
2024-08-08 2024-03-31 13F ORGANON COMMON STOCK 68622V106 270 270 5 0.0003
2024-01-13 2023-06-30 13F ORGANON & CO Stock 68622V106 0 -1,915 -100.00 0 -100.00
2023-02-10 2022-12-31 13F ORGANON & CO Stock 68622V106 1,915 1,915 53 0.0038
2023-02-10 2022-09-30 13F ORGANON & CO Stock 68622V106 0 -807 -100.00 0 -100.00
2022-08-11 2022-06-30 13F ORGANON & CO Stock 68622V106 807 807 27 0.0021
2022-04-29 2022-03-31 13F ORGANON & CO Stock 68622V106 0 -1,243 -100.00 0 -100.00
2022-02-10 2021-12-31 13F ORGANON & CO Stock 68622V106 1,243 1,243 38 0.0025
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.